Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.67 |
| ▸ | FAAH | O00519 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | XBP1 | P17861 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.64 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17192614 | 0.98 | MGLL (0.68) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14996147 | 0.98 | MGLL (0.68) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL7093769 | 0.94 | MGLL (0.62) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL24686928 | 0.89 | MGLL (0.61) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14134299 | 0.86 | MGLL (0.62) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL18515649 | 0.86 | MGLL (0.52) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL10147975 | 0.85 | MGLL (0.57) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL409521 | 0.85 | MGLL (0.64) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL10147978 | 0.83 | MGLL (0.59) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL28532542 | 0.83 | PTGS1 (0.46) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020217710-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC株式会社 | 2020-10-29 | — | — | WO | disclosed |
| US-9446139-B2 | Polymer-based compositions and conjugates of HIV entry inhibitors | NEKTAR THERAPEUTICS (US) | 2016-09-20 | — | — | US | disclosed |
| US-8895759-B2 | Intermediates useful in the preparation of maleimide functionalized polymers | NEKTAR THERAPEUTICS (US) | 2014-11-25 | — | — | US | disclosed |
| US-20140128619-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2014-05-08 | — | — | US | disclosed |
| US-8586711-B2 | Polymer-factor IX moiety conjugates | NEKTAR THERAPEUTICS (US) | 2013-11-19 | — | — | US | disclosed |
| US-8293869-B2 | Polymer conjugates of GLP-1 | NEKTAR THERAPEUTICS (US) | 2012-10-23 | — | — | US | disclosed |
| US-8273339-B2 | Polymer-based compositions and conjugates of antimicrobial agents | NEKTAR THERAPEUTICS (US) | 2012-09-25 | — | — | US | disclosed |
| US-20110171161-A1 | POLYMER CONJUGATES OF PROTEGRIN PEPTIDES | NEKTAR THERAPEUTICS (US) | 2011-07-14 | — | — | US | disclosed |
| US-20100249033-A1 | POLYMER FACTOR IX MOIETY CONJUGATES | NEKTAR THERAPEUTICS (US) | 2010-09-30 | — | — | US | disclosed |
| US-7790835-B2 | Water soluble, non-peptidic polymer covalently attached to a Diels-Alder bicyclic or tricyclic imide ring; chemical intermediates | NEKTAR THERAPEUTICS (US) | 2010-09-07 | — | — | US | disclosed |
| US-7714114-B2 | Conjugates of an EPO moiety and a polymer | NEKTAR THERAPEUTICS (US) | 2010-05-11 | — | — | US | disclosed |
| US-7579444-B2 | Polymer-factor IX moiety conjugates | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-08-25 | — | — | US | disclosed |
| WO-2008074004-A2 | HUMAN ANTIBODIES THAT BIND CD70 AND USES THEREOF | MEDAREX, INC. (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20070092482-A1 | Conjugates of a G-CSF moiety and a polymer | NEKTAR THERAPEUTICS | 2007-04-26 | — | — | US | disclosed |
| EP-0601974-B1 | Positive photoresist with better properties | OCG MICROELECTRONIC MATERIALS (US) | 1997-05-28 | — | — | EP | disclosed |
| US-5558978-A | Photoresist compositions containing copolymers having acid-labile groups and recurring units derived from either N-(hydroxymethyl)maleimide or N-(acetoxymethyl)maleimide or both | OCG MICROELECTRONIC MATERIALS, INC. (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0659781-A2 | Copolymers of maleimide, for photoresists | OCG Microelectronic Materials Inc. (US) | 1995-06-28 | — | — | EP | disclosed |
| US-5397680-A | Light sensitive elements with maleimide monomers and styrene derivatives polymers | CIBA-GEIGY AG (CH) | 1995-03-14 | — | — | US | disclosed |
| US-5369200-A | Positive photoresist having improved processing properties | CIBA-GEIGY AG (CH) | 1994-11-29 | — | — | US | disclosed |
| EP-0601974-A1 | Positive photoresist with better properties | OCG Microelectronic Materials Inc. (US) | 1994-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128619-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | DERA, MMAB, PAICS | MGLL 3710/4885FAAH 4109/4885ALDH1A1 74/4885 |
| US-20110171161-A1 | POLYMER CONJUGATES OF PROTEGRIN PEPTIDES | PSMG3, PSMB11, PSMC5 | MGLL 3264/4885FAAH 3421/4885ALDH1A1 4840/4885 |
| US-20100249033-A1 | POLYMER FACTOR IX MOIETY CONJUGATES | F9, F13A1, F8 | MGLL 3516/4885FAAH 3292/4885ALDH1A1 3118/4885 |
| US-20070092482-A1 | Conjugates of a G-CSF moiety and a polymer | CSF3R, GMFG, CSF1R | MGLL 1573/4885FAAH 3126/4885ALDH1A1 3741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.